{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:58:24Z","timestamp":1771300704201,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2009,6,3]],"date-time":"2009-06-03T00:00:00Z","timestamp":1243987200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1007\/s10822-009-9281-4","type":"journal-article","created":{"date-parts":[[2009,6,2]],"date-time":"2009-06-02T14:52:18Z","timestamp":1243954338000},"page":"527-539","source":"Crossref","is-referenced-by-count":80,"title":["Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide"],"prefix":"10.1007","volume":"23","author":[{"given":"Sameer","family":"Kawatkar","sequence":"first","affiliation":[]},{"given":"Hongming","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Ryszard","family":"Czerminski","sequence":"additional","affiliation":[]},{"given":"Diane","family":"Joseph-McCarthy","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,6,3]]},"reference":[{"key":"9281_CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1021\/jm800984v","volume":"52","author":"S Howard","year":"2009","unstructured":"Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, Curry J, Devine LA, Early TR, Fazal L, Gill AL, Heathcote M, Maman S, Matthews JE, McMenamin RL, Navarro EF, O\u2019Brien MA, O\u2019Reilly M, Rees DC, Reule M, Tisi D, Williams G, Vinkovic M, Wyatt PG (2009) Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. J Med Chem 52:379\u2013388. doi: 10.1021\/jm800984v","journal-title":"J Med Chem"},{"key":"9281_CR2","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm070829p","volume":"50","author":"PD Edwards","year":"2007","unstructured":"Edwards PD, Albert JS, Sylvester M, Aharony D, Andisik D, Callaghan O, Campbell JB, Carr RA, Chessari G, Congreve M, Frederickson M, Folmer RH, Geschwindner S, Koether G, Kolmodin K, Krumrine J, Mauger RC, Murray CW, Olsson LL, Patel S, Spear N, Tian G (2007) Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency. J Med Chem 50:5912\u20135925. doi: 10.1021\/jm070829p","journal-title":"J Med Chem"},{"key":"9281_CR3","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1021\/jm070825k","volume":"50","author":"S Geschwindner","year":"2007","unstructured":"Geschwindner S, Olsson LL, Albert JS, Deinum J, Edwards PD, de Beer T, Folmer RH (2007) Discovery of a novel warhead against beta-secretase through fragment-based lead generation. J Med Chem 50:5903\u20135911. doi: 10.1021\/jm070825k","journal-title":"J Med Chem"},{"key":"9281_CR4","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.2174\/156802607782341091","volume":"7","author":"JS Albert","year":"2007","unstructured":"Albert JS, Blomberg N, Breeze AL, Brown AJ, Burrows JN, Edwards PD, Folmer RH, Geschwindner S, Griffen EJ, Kenny PW, Nowak T, Olsson LL, Sanganee H, Shapiro AB (2007) An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca\u2019s drug discovery programmes. Curr Top Med Chem 7:1600\u20131629. doi: 10.2174\/156802607782341091","journal-title":"Curr Top Med Chem"},{"key":"9281_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev.biophys.33.110502.140409","volume":"33","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, Wells JA, Braisted AC (2004) Tethering: fragment-based drug discovery. Annu Rev Biophys Biomol Struct 33:199\u2013223. doi: 10.1146\/annurev.biophys.33.110502.140409","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"9281_CR6","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/jm701509k","volume":"51","author":"M Hohwy","year":"2008","unstructured":"Hohwy M, Spadola L, Lundquist B, Hawtin P, Dahmen J, Groth-Clausen I, Nilsson E, Persdotter S, von Wachenfeldt K, Folmer RH, Edman K (2008) Novel prostaglandin D synthase inhibitors generated by fragment-based drug design. J Med Chem 51:2178\u20132186. doi: 10.1021\/jm701509k","journal-title":"J Med Chem"},{"key":"9281_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6:29\u201340. doi: 10.1038\/nrd2201","journal-title":"Nat Rev Drug Discov"},{"key":"9281_CR8","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S1359-6446(04)03069-7","volume":"9","author":"AL Hopkins","year":"2004","unstructured":"Hopkins AL, Groom CR, Alex A (2004) Ligand efficiency: a useful metric for lead selection. Drug Discov Today 9:430\u2013431. doi: 10.1016\/S1359-6446(04)03069-7","journal-title":"Drug Discov Today"},{"key":"9281_CR9","doi-asserted-by":"crossref","first-page":"9997","DOI":"10.1073\/pnas.96.18.9997","volume":"96","author":"ID Kuntz","year":"1999","unstructured":"Kuntz ID, Chen K, Sharp KA, Kollman PA (1999) The maximal affinity of ligands. Proc Natl Acad Sci USA 96:9997\u201310002. doi: 10.1073\/pnas.96.18.9997","journal-title":"Proc Natl Acad Sci USA"},{"key":"9281_CR10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1359-6446(05)03386-6","volume":"10","author":"C Abad-Zapatero","year":"2005","unstructured":"Abad-Zapatero C, Metz JT (2005) Ligand efficiency indices as guideposts for drug discovery. Drug Discov Today 10:464\u2013469. doi: 10.1016\/S1359-6446(05)03386-6","journal-title":"Drug Discov Today"},{"key":"9281_CR11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1359-6446(05)03511-7","volume":"10","author":"RAE Carr","year":"2005","unstructured":"Carr RAE, Congreve M, Murray CW, Rees DC (2005) Fragment-based lead discovery: leads by design. Drug Discov Today 10:987\u2013992. doi: 10.1016\/S1359-6446(05)03511-7","journal-title":"Drug Discov Today"},{"key":"9281_CR12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3\u201325. doi: 10.1016\/S0169-409X(96)00423-1","journal-title":"Adv Drug Deliv Rev"},{"key":"9281_CR13","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008130001697","volume":"14","author":"TI Oprea","year":"2000","unstructured":"Oprea TI (2000) Property distribution of drug-related chemical databases. J Comput Aided Mol Des 14:251\u2013264. doi: 10.1023\/A:1008130001697","journal-title":"J Comput Aided Mol Des"},{"key":"9281_CR14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1021\/ci010366a","volume":"41","author":"TI Oprea","year":"2001","unstructured":"Oprea TI, Davis AM, Teague SJ, Leeson PD (2001) Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 41:1308\u20131315. doi: 10.1021\/ci010366a","journal-title":"J Chem Inf Comput Sci"},{"key":"9281_CR15","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. doi: 10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"9281_CR16","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","volume":"8","author":"M Congreve","year":"2003","unstructured":"Congreve M, Carr R, Murray C, Jhoti H (2003) A \u2018rule of three\u2019 for fragment-based lead discovery? Drug Discov Today 8:876\u2013877. doi: 10.1016\/S1359-6446(03)02831-9","journal-title":"Drug Discov Today"},{"key":"9281_CR17","first-page":"264","volume":"10","author":"D Joseph-McCarthy","year":"2007","unstructured":"Joseph-McCarthy D, Baber JC, Feyfant E, Thompson DC, Humblet C (2007) Lead optimization via high-throughput molecular docking. Curr Opin Drug Discov Dev 10:264\u2013274","journal-title":"Curr Opin Drug Discov Dev"},{"key":"9281_CR18","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK, Shaw DE, Francis P, Shenkin PS (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. doi: 10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"9281_CR19","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750\u20131759. doi: 10.1021\/jm030644s","journal-title":"J Med Chem"},{"key":"9281_CR20","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner RA, Murphy RB, Repasky MP, Frye LL, Greenwood JR, Halgren TA, Sanschagrin PC, Mainz DT (2006) Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J Med Chem 49:6177\u20136196. doi: 10.1021\/jm051256o","journal-title":"J Med Chem"},{"key":"9281_CR21","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1021\/jm701509k","volume":"51","author":"M Hohwy","year":"2008","unstructured":"Hohwy M, Spadola L, Lundquist B, Hawtin P, Dahm\u00e9n J, Groth-Clausen I, Nilsson E, Persdotter S, von Wachenfeldt K, Folmer R, Edman K (2008) Novel prostaglandin D synthase inhibitors generated by fragment-based drug design. J Med Chem 51:2178\u20132186. doi: 10.1021\/jm701509k","journal-title":"J Med Chem"},{"key":"9281_CR22","doi-asserted-by":"crossref","first-page":"15277","DOI":"10.1074\/jbc.M506431200","volume":"281","author":"K Aritake","year":"2006","unstructured":"Aritake K, Kado Y, Inoue T, Miyano M, Urade Y (2006) Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem 281:15277\u201315286. doi: 10.1074\/jbc.M506431200","journal-title":"J Biol Chem"},{"key":"9281_CR23","first-page":"3","volume-title":"The enzymes","author":"MJ Engler","year":"1982","unstructured":"Engler MJ, Richardson CC (1982) DNA ligases. In: Boyer PD (ed) The enzymes. Academic Press, Inc., New York, NY, pp 3\u201329"},{"key":"9281_CR24","unstructured":"Kenny PW (2009) J Comput Aided Mol Des In (this issue)"},{"key":"9281_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","volume":"28","author":"D Weininger","year":"1988","unstructured":"Weininger D (1988) SMILES 1. Introduction and encoding rules. J Chem Inf Comput 28:31\u201336","journal-title":"J Chem Inf Comput"},{"key":"9281_CR26","first-page":"271","volume-title":"Chemoinformatics in drug discovery","author":"PW Kenny","year":"2004","unstructured":"Kenny PW, Sadowski J (2004) Structure modification in chemical databases. In: Opera TI (ed) Chemoinformatics in drug discovery. Wiley, Weinheim, pp 271\u2013285"},{"key":"9281_CR27","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1021\/jm060522a","volume":"49","author":"PD Lyne","year":"2006","unstructured":"Lyne PD, Lamb ML, Saeh JC (2006) Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. J Med Chem 49:4805\u20134808. doi: 10.1021\/jm060522a","journal-title":"J Med Chem"},{"key":"9281_CR28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1021\/ci0503255","volume":"46","author":"HM Chen","year":"2006","unstructured":"Chen HM, Lyne PD, Giordanetto F, Lovell T, Li J (2006) Evaluating molecular-docking methods for pose prediction and enrichment factors. J Chem Inf Model 46:401\u2013415. doi: 10.1021\/ci0503255","journal-title":"J Chem Inf Model"},{"key":"9281_CR29","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/jm049092j","volume":"48","author":"N Triballeau","year":"2005","unstructured":"Triballeau N, Acher F, Brabet I, Pin JP, Bertrand HO (2005) Virtual screening workflow development guided by the \u201creceiver operating characteristic\u201d curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem 48:2534\u20132547. doi: 10.1021\/jm049092j","journal-title":"J Med Chem"},{"key":"9281_CR30","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: visualizing classifier performance in R. Bioinformatics 21:3940\u20133941. doi: 10.1093\/bioinformatics\/bti623","journal-title":"Bioinformatics"},{"key":"9281_CR31","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","volume":"49","author":"W Sherman","year":"2006","unstructured":"Sherman W, Day T, Jacobson MP, Friesner RA, Farid R (2006) Novel procedure for modeling ligand\/receptor induced fit effects. J Med Chem 49:534\u2013553. doi: 10.1021\/jm050540c","journal-title":"J Med Chem"},{"key":"9281_CR32","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1021\/ci8002254","volume":"48","author":"ML Verdonk","year":"2008","unstructured":"Verdonk ML, Mortenson PN, Hall RJ, Hartshorn MJ, Murray CW (2008) Protein-ligand docking against non-native protein conformers. J Chem Inf Model 48:2214\u20132225. doi: 10.1021\/ci8002254","journal-title":"J Chem Inf Model"},{"key":"9281_CR33","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jmb.2008.01.049","volume":"377","author":"AP Graves","year":"2008","unstructured":"Graves AP, Shivakumar DM, Boyce SE, Jacobson MP, Case DA, Shoichet BK (2008) Rescoring docking hit lists for model cavity sites: predictions and experimental testing. J Mol Biol 377:914\u2013934. doi: 10.1016\/j.jmb.2008.01.049","journal-title":"J Mol Biol"},{"key":"9281_CR34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/ci700470c","volume":"48","author":"DC Thompson","year":"2008","unstructured":"Thompson DC, Humblet C, Joseph-McCarthy D (2008) Investigation of MM-PBSA rescoring of docking poses. J Chem Inf Model 48:1081\u20131091. doi: 10.1021\/ci700470c","journal-title":"J Chem Inf Model"},{"key":"9281_CR35","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1021\/jm049798d","volume":"48","author":"MD Cummings","year":"2005","unstructured":"Cummings MD, DesJarlais RL, Gibbs AC, Mohan V, Jaeger EP (2005) Comparison of automated docking programs as virtual screening tools. J Med Chem 48:962\u2013976. doi: 10.1021\/jm049798d","journal-title":"J Med Chem"},{"key":"9281_CR36","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS (2006) A critical assessment of docking programs and scoring functions. J Med Chem 49:5912\u20135931. doi: 10.1021\/jm050362n","journal-title":"J Med Chem"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9281-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-009-9281-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-009-9281-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T01:23:00Z","timestamp":1559265780000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-009-9281-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,3]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["9281"],"URL":"https:\/\/doi.org\/10.1007\/s10822-009-9281-4","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,3]]}}}